324 related articles for article (PubMed ID: 15726528)
1. Preclinical perspectives on the use of platinum compounds in cancer chemotherapy.
Farrell NP
Semin Oncol; 2004 Dec; 31(6 Suppl 14):1-9. PubMed ID: 15726528
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity.
Saldivar JS; Wu X; Follen M; Gershenson D
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S56-71. PubMed ID: 17884153
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance of human tumours to anticancer drugs of the platinum family: a review.
Ferguson PJ
J Otolaryngol; 1995 Aug; 24(4):242-52. PubMed ID: 8551538
[TBL] [Abstract][Full Text] [Related]
4. Platinum-based anticancer agents: innovative design strategies and biological perspectives.
Ho YP; Au-Yeung SC; To KK
Med Res Rev; 2003 Sep; 23(5):633-55. PubMed ID: 12789689
[TBL] [Abstract][Full Text] [Related]
5. [Platinum salts: cytotoxic mechanisms of action, mechanisms of resistance of cancer cells, interactions with ionizing radiation, specificity of carboplatin].
Rixe O
Bull Cancer; 2000 Aug; 87 Spec No():7-15. PubMed ID: 11082717
[TBL] [Abstract][Full Text] [Related]
6. The resurgence of platinum-based cancer chemotherapy.
Kelland L
Nat Rev Cancer; 2007 Aug; 7(8):573-84. PubMed ID: 17625587
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of platinum resistance: still searching for the Achilles' heel.
Wernyj RP; Morin PJ
Drug Resist Updat; 2004; 7(4-5):227-32. PubMed ID: 15533760
[TBL] [Abstract][Full Text] [Related]
8. The development of platinum compounds and their possible combination.
Pasetto LM; D'Andrea MR; Brandes AA; Rossi E; Monfardini S
Crit Rev Oncol Hematol; 2006 Oct; 60(1):59-75. PubMed ID: 16806960
[TBL] [Abstract][Full Text] [Related]
9. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
Muggia FM
Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
[TBL] [Abstract][Full Text] [Related]
10. Cellular processing of platinum anticancer drugs.
Wang D; Lippard SJ
Nat Rev Drug Discov; 2005 Apr; 4(4):307-20. PubMed ID: 15789122
[TBL] [Abstract][Full Text] [Related]
11. Basis for design and development of platinum(IV) anticancer complexes.
Hall MD; Mellor HR; Callaghan R; Hambley TW
J Med Chem; 2007 Jul; 50(15):3403-11. PubMed ID: 17602547
[No Abstract] [Full Text] [Related]
12. [Advances in research on the association between single nucleotide polymorphisms of the DNA repair genes and resistance to platinum-based chemotherapy].
Wei J; Liu BR; Wang YP
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):161-3. PubMed ID: 16875596
[No Abstract] [Full Text] [Related]
13. Evolution of chemotherapy with platinum compounds.
Walker EM; Walker SM
Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825
[TBL] [Abstract][Full Text] [Related]
14. The problem with platinum.
Holmes D
Nature; 2015 Nov; 527(7579):S218-9. PubMed ID: 26605762
[No Abstract] [Full Text] [Related]
15. A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity.
Griffith D; Morgan MP; Marmion CJ
Chem Commun (Camb); 2009 Nov; (44):6735-7. PubMed ID: 19885462
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of drug resistance.
Longley DB; Johnston PG
J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent ovarian cancer relapsing 6-12 months post platinum-based chemotherapy.
Colombo N; Gore M
Crit Rev Oncol Hematol; 2007 Nov; 64(2):129-38. PubMed ID: 17566758
[TBL] [Abstract][Full Text] [Related]
19. Non platinum metal complexes as anti-cancer drugs.
Ott I; Gust R
Arch Pharm (Weinheim); 2007 Mar; 340(3):117-26. PubMed ID: 17315259
[TBL] [Abstract][Full Text] [Related]
20. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma.
Belani CP
Semin Oncol; 2004 Dec; 31(6 Suppl 14):25-33. PubMed ID: 15726531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]